Precision Medicine

Ad: Extracting value from healthcare requires a strong data foundation.

How precision medicine can foster better outcomes for patients and better lives for physicians.

But a new study suggests the tool can help eliminate waste.

The tools could optimize nutrition and quantify gut health to decrease the length of stay in the neonatal intensive care unit.

The tech allows individuals to share their health data and receive ownership shares in the organization

The companies aim to tackle precision medicine through a nanoparticle program.

Use of the genetic test could save these populations hundreds of thousands of dollars a year in healthcare costs.

Ad: How SAP supports critical data and analytics to create a 360-degree view of the patient.

At-home blood testing could soon become a reality.

Fresh out of Health Datapalooza, Janae Sharp explores how the conference circuit shows what’s wrong with healthcare — and how we might fix it.

Neutron tomography is time consuming but highly accurate.

The service could help accelerate the development of gene and cell therapy.

The institute will bring together industry leaders to develop digital health products that could empower patients and providers and improve health outcomes.

Recurrence score testing was associated with lower costs among high-risk cancer patients.

The partnership aims to bridge the gap between DTC testing and medical-grade genetic testing.

It could be possible to identify infectious diseases using a smartphone, according to a new study.

A revised guidance aims to modernize clinical trials and ensure the safety and efficacy of novel treatments.

Heritable genome editing is said to be too unpredictable, unsafe and unnecessary.

The health and genetics data available for use could lead to more scientific breakthroughs that can improve health outcomes.

With the new data, researchers could begin developing better treatments for a range of diseases.

Clinical whole genome sequencing can reduce unresolved chronic genetic disease cases. But the technology has to be used properly.

#HIMSS19: How Andrew Pecora, M.D. is combining the literature with social determinants of health and previous cases to inform clinical decision making at the point of care.

Its data-driven push toward precision medicine is working. Why?

The week’s health-tech news that you can’t miss.

The direct-to-consumer genetic testing market goes further in the green.

Kevin Campbell, M.D., will lead a webinar on data, value and precision cardiovascular medicine.

The move puts Helix in Denver’s vibrant tech market.

Invitae just published a study that it says shows the necessity of looking for dupications and deletions when testing.

Last summer, its parent company trademarked a wordmark that reads “The Future of Surgery.”

Ethics, interoperability, and the wearables revolution dominated our reading (and listening) this week.